Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
RegeneRx Licensee Receives FDA Permission to Conduct a Phase 3 Trial of RGN-137
Tuesday, February 28, 2017RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that its licensee for RGN GtreeBNT Co Ltd received a positive response from the US FDA for its Phase clinic...
Arsanis Inc., and Adimab Enter Into License Agreement
Tuesday, February 28, 2017Arsanis Inc a clinicalstage biopharmaceutical company developing targeted monoclonal antibodies for preemptive and postinfection treatment of serious infectious diseases and Adimab LLC the global leader in the discovery and optimization of fully huma...
Perrigo Signs Agreement To Divest Tysabri® Royalty Stream For Up To $2.85 Billion
Tuesday, February 28, 2017Perrigo Company plc a leading global provider of Quality Affordable Healthcare Products today announced it has signed a definitive agreement to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri n...
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR
Monday, February 27, 2017Intellipharmaceutics International Inc NasdaqIPCI TSXI Intellipharmaceutics or the Company a pharmaceutical company specializing in the research development and manufacture of novel and generic controlledrelease and targetedrelease oral solid dosage...
Xynomic Pharma has Acquired Worldwide Rights of Abexinostat
Monday, February 27, 2017Xynomic Pharmaceuticals Inc an oncology drug research and development company today announced that it has acquired exclusive worldwide rights to develop manufacture and commercialize Abexinostat a potentially bestinclass innovative HDAC inhibitor tar...
Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
Monday, February 27, 2017Sanofi and Lonza announced today that they have entered into a strategic partnership to build and operate a largescale mammalian cell culture facility for monoclonal antibody production in Visp Switzerland The strategic partnership in the form of a j...
Novartis wins CHMP nod for drug combo against some lung cancers
Saturday, February 25, 2017Swiss drugmaker Novartiss drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a recommendation to expand the combinations indications The Europe...
ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®
Saturday, February 25, 2017ANI Pharmaceuticals Inc announced that it has acquired Inderal XL from Cranford Pharmaceuticals LLC and InnoPran XL from Holmdel Pharmaceuticals LP The acquired assets include the NDA and trademark for InnoPran XL including a license to an Orange Boo...
Cyclacel's leukemia drug for elderly patients fails in key study
Friday, February 24, 2017Cyclacel Pharmaceuticals Inc said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a latestage study The drug developers stock was down about percent in light premarket trading on Thursday The...
Finch Therapeutics Announces Strategic Collaboration with OpenBiome
Friday, February 24, 2017Finch Therapeutics Inc a microbiome therapeutics company and OpenBiome a leading public stool bank today announced a collaboration to develop FIN an orally administered microbial therapy for approval by US Food and Drug Administration FDA in recurren...
